Christopher C. Gibson Ph.D.
Net Worth

Last updated:

What is Christopher C. Gibson Ph.D. net worth?

The estimated net worth of Dr. Christopher C. Gibson Ph.D. is at least $28,000,003 as of 5 Dec 2024. He owns shares worth $3,690,531 as insider, has earned $23,046,312 from insider trading and has received compensation worth at least $1,263,160 in Recursion Pharmaceuticals, Inc..

What is the salary of Christopher C. Gibson Ph.D.?

Dr. Christopher C. Gibson Ph.D. salary is $315,790 per year as Co-Founder, Chief Executive Officer & Director in Recursion Pharmaceuticals, Inc..

How old is Christopher C. Gibson Ph.D.?

Dr. Christopher C. Gibson Ph.D. is 42 years old, born in 1983.

What stocks does Christopher C. Gibson Ph.D. currently own?

As insider, Dr. Christopher C. Gibson Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Recursion Pharmaceuticals, Inc. (RXRX) Co-Founder, Chief Executive Officer & Director 736,633 $5.01 $3,690,531

What does Recursion Pharmaceuticals, Inc. do?

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 to treat familial adenomatous polyposis; and REC-3599, which is in Phase I clinical trial to treat GM2 gangliosidosis. Its preclinical stage product includes REC-3964 to treat Clostridium difficile colitis; REC-64917 for the treat of neural or systemic inflammation; REC-65029 to treat HRD-negative ovarian cancer; REC-648918 to enhance anti-tumor immune; REC-2029 for the treatment of wnt-mutant hepatocellular carcinoma; REC-14221 to treat solid and hematological malignancies; and REC-64151 for the treatment of immune checkpoint resistance in KRAS/STK11 mutant non-small cell lung cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

RXRX logo
RXRX
Recursion Pharmaceuticals, Inc.
$5.01

Christopher C. Gibson Ph.D. insider trading

Recursion Pharmaceuticals, Inc.

Dr. Christopher C. Gibson Ph.D. has made 105 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he sold 20,000 units of RXRX stock worth $142,400 on 5 Dec 2024.

The largest trade he's ever made was exercising 300,000 units of RXRX stock on 7 Mar 2022. As of 5 Dec 2024 he still owns at least 736,633 units of RXRX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Class A Common Stock 20,000 $7.12 $142,400
Sale
Class A Common Stock 20,000 $7.16 $143,200
Sale
Class A Common Stock 20,000 $7.35 $147,000
Sale
Class A Common Stock 20,000 $7.74 $154,800
Sale
Class A Common Stock 20,000 $6.08 $121,600
Sale
Class A Common Stock 20,000 $6.16 $123,200
Sale
Class A Common Stock 20,000 $6.14 $122,800
Sale
Class A Common Stock 20,000 $6.04 $120,800
Option
Class A Common Stock 5,000 $2.48 $12,400
Option
Stock Option (Right to Buy) 5,000 $2.48 $12,400
Option
Class A Common Stock 5,000 $2.48 $12,400
Option
Stock Option (Right to Buy) 5,000 $2.48 $12,400
Option
Class A Common Stock 5,000 $2.48 $12,400
Option
Stock Option (Right to Buy) 5,000 $2.48 $12,400
Option
Stock Option (Right to Buy) 5,000 $2.48 $12,400
Option
Class A Common Stock 5,000 $2.48 $12,400
Option
Stock Option (Right to Buy) 5,000 $2.48 $12,400
Option
Class A Common Stock 5,000 $2.48 $12,400
Option
Stock Option (Right to Buy) 5,000 $2.48 $12,400
Option
Class A Common Stock 5,000 $2.48 $12,400
Sale
Class A Common Stock 21,296 $8.47 $180,377
Sale
Class A Common Stock 50,000 $7.73 $386,500
Sale
Class A Common Stock 40,000 $9.02 $360,800
Sale
Class A Common Stock 25,000 $9.02 $225,500
Sale
Class A Common Stock 25,000 $8.84 $221,000
Sale
Class A Common Stock 40,000 $8.84 $353,600
Option
Class B Common Stock 25,000 N/A N/A
Sale
Class A Common Stock 40,000 $10.1 $404,000
Sale
Class A Common Stock 25,000 $10.1 $252,500
Sale
Class A Common Stock 36,319 $11.86 $430,671
Option
Class A Common Stock 8,674 $11.4 $98,884
Option
Class A Common Stock 31,250 $2.48 $77,500
Option
Stock Option (Right to Buy) 31,250 $2.48 $77,500
Option
Stock Option (Right to Buy) 8,674 $11.4 $98,884
Sale
Class A Common Stock 25,000 $11.56 $288,975
Option
Class A Common Stock 31,250 $2.48 $77,500
Option
Stock Option (Right to Buy) 31,250 $2.48 $77,500
Sale
Class A Common Stock 37,177 $5.2 $193,320
Sale
Class A Common Stock 25,000 $5.13 $128,275
Option
Class A Common Stock 31,250 $2.48 $77,500
Sale
Class A Common Stock 59,794 $7.21 $431,055
Option
Stock Option (Right to Buy) 31,250 $2.48 $77,500
Option
Class A Common Stock 31,250 $2.48 $77,500
Option
Stock Option (Right to Buy) 31,250 $2.48 $77,500
Sale
Class A Common Stock 33,765 $8.78 $296,592
Sale
Class A Common Stock 25,000 $8.84 $220,875
Option
Class A Common Stock 31,250 $2.48 $77,500
Option
Class A Common Stock 8,674 $11.4 $98,884
Option
Stock Option (Right to Buy) 8,674 $11.4 $98,884
Sale
Class A Common Stock 60,955 $13.02 $793,451
Sale
Class A Common Stock 4,060 $13.36 $54,254
Option
Class A Common Stock 31,250 $2.48 $77,500
Option
Stock Option (Right to Buy) 31,250 $2.48 $77,500
Sale
Class A Common Stock 127 $12.36 $1,569
Sale
Class A Common Stock 850 $12.41 $10,547
Sale
Class A Common Stock 561 $11.83 $6,634
Sale
Class A Common Stock 3,423 $10.87 $37,194
Sale
Class A Common Stock 7,898 $11.8 $93,173
Sale
Class A Common Stock 3,270 $12.39 $40,505
Option
Stock Option (Right to Buy) 31,250 $2.48 $77,500
Option
Class A Common Stock 31,250 $2.48 $77,500
Sale
Class A Common Stock 17,227 $14.34 $247,104
Sale
Class A Common Stock 4,430 $10.84 $48,012
Sale
Class A Common Stock 10,327 $11.74 $121,280
Sale
Class A Common Stock 850 $10.82 $9,198
Sale
Class A Common Stock 2,173 $11.8 $25,644
Sale
Class A Common Stock 236 $10.87 $2,565
Sale
Class A Common Stock 4,693 $12.41 $58,254
Sale
Class A Common Stock 690 $14.31 $9,876
Sale
Class A Common Stock 63 $13.75 $867
Option
Class A Common Stock 31,250 $2.48 $77,500
Sale
Class A Common Stock 56,436 $9.05 $510,802
Option
Stock Option (Right to Buy) 31,250 $2.48 $77,500
Option
Stock Option (Right to Buy) 31,250 $2.48 $77,500
Option
Class A Common Stock 31,250 $2.48 $77,500
Sale
Class A Common Stock 33,073 $4.71 $155,774
Sale
Class A Common Stock 25,000 $4.91 $122,700
Sale
Class A Common Stock 40,000 $6.64 $265,680
Option
Stock Option (Right to Buy) 31,250 $2.48 $77,500
Option
Class A Common Stock 31,250 $2.48 $77,500
Sale
Class A Common Stock 13,327 $6.46 $86,039
Sale
Class A Common Stock 15,000 $7.78 $116,625
Option
Stock Option (Right to Buy) 93,750 $2.48 $232,500
Option
Class A Common Stock 93,750 $2.48 $232,500
Sale
Class A Common Stock 1,000 $8.09 $8,087
Sale
Class A Common Stock 70,890 $8.1 $573,925
Sale
Class A Common Stock 18,500 $7.92 $146,502
Sale
Class A Common Stock 1,000 $7.91 $7,909
Sale
Class A Common Stock 1,000 $9.2 $9,202
Sale
Class A Common Stock 18,500 $9.22 $170,552
Sale
Class A Common Stock 18,500 $7.39 $136,678
Sale
Class A Common Stock 1,000 $7.38 $7,382
Sale
Class A Common Stock 18,500 $9.28 $171,625
Option
Stock Option (Right to Buy) 31,250 $2.48 $77,500
Option
Class A Common Stock 31,250 $2.48 $77,500
Sale
Class A Common Stock 1,000 $9.28 $9,277
Option
Stock Option (Right to Buy) 31,250 $2.48 $77,500
Option
Class A Common Stock 31,250 $2.48 $77,500
Sale
Class A Common Stock 18,500 $10.11 $187,035
Sale
Class A Common Stock 1,000 $10.1 $10,099
Sale
Class A Common Stock 1,000 $11.64 $11,641
Sale
Class A Common Stock 18,500 $11.65 $215,544
Option
Class A Common Stock 31,250 $2.48 $77,500
Option
Stock Option (Right to Buy) 31,250 $2.48 $77,500
Option
Class A Common Stock 31,250 $2.48 $77,500
Sale
Class A Common Stock 1,000 $10.5 $10,504
Sale
Class A Common Stock 18,500 $10.49 $194,047
Option
Stock Option (Right to Buy) 31,250 $2.48 $77,500
Sale
Class A Common Stock 1,000 $9.45 $9,447
Option
Class A Common Stock 31,250 $2.48 $77,500
Option
Stock Option (Right to Buy) 31,250 $2.48 $77,500
Sale
Class A Common Stock 18,500 $9.45 $174,881
Option
Stock Option (Right to Buy) 31,250 $2.48 $77,500
Sale
Class A Common Stock 18,500 $9.07 $167,740
Sale
Class A Common Stock 1,000 $9.07 $9,068
Option
Class A Common Stock 31,250 $2.48 $77,500
Option
Class A Common Stock 31,250 $2.48 $77,500
Sale
Class A Common Stock 18,500 $6.35 $117,383
Sale
Class A Common Stock 1,000 $6.34 $6,341
Option
Stock Option (Right to Buy) 31,250 $2.48 $77,500
Sale
Class A Common Stock 18,500 $6.44 $119,122
Sale
Class A Common Stock 1,000 $6.44 $6,439
Option
Stock Option (Right to Buy) 31,250 $2.48 $77,500
Sale
Class A Common Stock 18,500 $6.48 $119,862
Sale
Class A Common Stock 1,000 $6.47 $6,474
Option
Class A Common Stock 31,250 $2.48 $77,500
Option
Stock Option (Right to Buy) 44,010 $2.48 $109,145
Option
Stock Option (Right to Buy) 44,010 $2.48 $109,145
Option
Class A Common Stock 44,014 $2.48 $109,155
Sale
Class A Common Stock 1,000 $6.31 $6,308
Sale
Class A Common Stock 18,500 $6.3 $116,569
Sale
Class A Common Stock 1,000 $6.07 $6,071
Option
Class A Common Stock 44,010 $2.48 $109,145
Sale
Class A Common Stock 18,500 $6.08 $112,554
Option
Stock Option (Right to Buy) 44,010 $2.48 $109,145
Option
Stock Option (Right to Buy) 44,010 $2.48 $109,145
Sale
Class A Common Stock 18,500 $6 $111,074
Option
Class A Common Stock 44,010 $2.48 $109,145
Sale
Class A Common Stock 1,000 $6.01 $6,005
Sale
Class A Common Stock 1,000 $6.19 $6,185
Sale
Class A Common Stock 18,500 $6.19 $114,460
Option
Class A Common Stock 44,010 $2.48 $109,145
Sale
Class A Common Stock 1,000 $6.71 $6,706
Sale
Class A Common Stock 18,500 $6.7 $123,895
Option
Class A Common Stock 44,010 $2.48 $109,145
Option
Stock Option (Right to Buy) 44,010 $2.48 $109,145
Sale
Class A Common Stock 18,500 $7.51 $138,880
Sale
Class A Common Stock 1,000 $7.51 $7,513
Option
Stock Option (Right to Buy) 44,010 $2.48 $109,145
Option
Class A Common Stock 44,010 $2.48 $109,145
Option
Stock Option (Right to Buy) 44,010 $2.47 $108,705
Sale
Class A Common Stock 1,000 $6.71 $6,713
Option
Class A Common Stock 44,010 $2.48 $109,145
Sale
Class A Common Stock 18,500 $6.72 $124,357
Sale
Class A Common Stock 1,000 $6.52 $6,522
Option
Stock Option (Right to Buy) 44,010 $2.47 $108,705
Sale
Class A Common Stock 18,500 $6.53 $120,787
Option
Class A Common Stock 44,010 $2.48 $109,145
Option
Stock Option (Right to Buy) 44,010 $2.47 $108,705
Sale
Class A Common Stock 1,000 $6.56 $6,561
Option
Class A Common Stock 44,010 $2.48 $109,145
Sale
Class A Common Stock 18,500 $6.56 $121,434
Option
Class A Common Stock 44,010 $2.48 $109,145
Sale
Class A Common Stock 18,500 $7.31 $135,180
Sale
Class A Common Stock 1,000 $7.31 $7,309
Option
Stock Option (Right to Buy) 44,010 $2.47 $108,705
Sale
Class A Common Stock 6,150 $6.08 $37,410
Sale
Class A Common Stock 230,000 $6.28 $1,444,860
Sale
Class A Common Stock 100,000 $6.95 $694,600
Sale
Class A Common Stock 300,000 $7.3 $2,189,100
Sale
Class A Common Stock 100,000 $10.22 $1,021,500
Sale
Class A Common Stock 19,858 $11.73 $232,974
Sale
Class A Common Stock 254,000 $13.57 $3,445,510
Sale
Class A Common Stock 87,000 $14.61 $1,271,070
Sale
Class A Common Stock 200 $20.01 $4,001
Sale
Class A Common Stock 100 $20.02 $2,002
Sale
Class A Common Stock 1,086 $20.01 $21,730
Option
Stock Option (Right to Buy) 28,646 $2.47 $70,756
Sale
Class A Common Stock 5,488 $20.26 $111,165
Option
Class A Common Stock 28,646 $2.47 $70,756
Sale
Class B Common Stock 19,792 $20.76 $410,961

Recursion Pharmaceuticals key executives

Recursion Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: